Eli Lilly and Company

Medical Science Liaison (m/w/d) Mammakarzinom (Gebiet Mitte)

Germany

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Job Description: Medical Sciences Liaison (m/w/d) Onkologie/Mammakarzinom – Region Mitte

Position Overview

  • Company: Eli Lilly and Company
  • Employment Type: Full-time
  • Location Type: Onsite
  • Location: Bad Homburg bei Frankfurt am Main, Germany
  • Start Date: Immediately

Description: Eli Lilly and Company is a global healthcare leader dedicated to discovering and bringing life-changing medicines to those who need them. With a history dating back to 1876, Lilly is committed to uniting caring with discovery and improving the lives of millions worldwide. The company focuses on key therapeutic areas including Alzheimer's disease, pain, cancer, immunology, diabetes, and obesity. Lilly Deutschland GmbH, a subsidiary, has been operating in Germany since 1960 and employs over 1,100 people. Lilly's mission is to positively change the lives of people – through the exploration of medications, a better understanding of disease management, and by supporting patients, their families, and friends.

Responsibilities

  • (Responsibilities are not explicitly listed in the provided text. This section would be populated with details from a complete job description.)

Benefits

  • Work Environment: Collaborative and respectful, with an “you” culture.
  • Autonomy: Freedom to contribute ideas and implement them independently, often within cross-functional or self-organized teams.
  • Work-Life Balance: Flexible working hours based on trust.
  • Development: Individual career development support and access to professional training through the "Corporate Lilly University."
  • Financial Benefits: Attractive compensation package.

Requirements

  • (Requirements are not explicitly listed in the provided text. This section would be populated with details from a complete job description.)

Company Information

  • Company Name: Eli Lilly and Company
  • Founded: 1876
  • Headquarters: Indianapolis, Indiana, USA
  • Global Employees: Over 45,000
  • Key Therapeutic Areas: Alzheimer’s disease, pain, cancer, immunology, diabetes, and obesity.
  • German Subsidiary: Lilly Deutschland GmbH (based in Bad Homburg vor der Höhe, Hesse)

Skills

Oncology
Mammakarzinom
Medical Science Liaison
Cancer
Immunology
Diabetes
Alzheimer's disease
Obesity

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI